Article

The Contributions of Vaccination and Natural Infection to the Production of Neutralizing Antibodies Against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Prototype Strain and Variants

2023-08-14

Abstract excerpt

Background: This study aimed to evaluate the neutralizing antibody (NAbs) levels against the SARS-CoV-2 Omicron variants BF.7, BQ.1, BQ.1.1, XBB.1, and XBB.1.5.<br><br>Methods: The NAbs against the different viral strains of 490 SARS-CoV-2 infected and 187 uninfected individuals during the Beijing December 2022 to January 2023 outbreak were analyzed.<br><br>Findings: In individuals without prior infection, the adm...

Topics

Open a Topic to create a Post that cites this publication.

Identifiers and source

Literature Corpus work: 088b65c6-4aa8-5a68-adc9-dd03f9d0d10b
DOI: 10.2139/ssrn.4536067

Open publication

Related research

Semantic proximity does not establish scientific evidence.

Click a neighbor to travelStep 1 · 12 closest

The Contributions of Vaccination and Natural Infection to the Production of Neutralizing Antibodies Against the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Prototype Strain and VariantsDOI 10.2139/ssrn.4536067Read

The Impact of SARS-CoV-2 Vaccination and Infection on Neutralising Antibodies: A Nation-Wide Cross-Sectional AnalysisSemantic proximity Read

SARS-CoV-2 variants of concern exhibit reduced sensitivity to live-virus neutralization in sera from CoronaVac vaccinees and naturally infected COVID-19 patientsSemantic proximity Read

Effectiveness of a booster dose of COVID-19 vaccines during an outbreak of SARS-CoV-2 Omicron BA.2 in China: A case-control studySemantic proximity Read

Functional and quantitative evaluation of BNT162b2 SARS-CoV-2 vaccine-induced immunitySemantic proximity Read

Inactivated vaccine fueled adaptive immune responses to Omicron in 2-year COVID-19 convalescentsSemantic proximity Read

Long-term neutralizing antibody dynamics against SARS-CoV-2 in symptomatic and asymptomatic infections: a systematic review and meta-analysisSemantic proximity Read

The Effectiveness of the First Dose of BNT162b2 Vaccine in Reducing SARS-CoV-2 Infection: Real-World EvidenceSemantic proximity Read

Demographic and Clinical Factors Associated With Anti–SARS-CoV-2 Antibody Levels After 2 BNT162b2 mRNA Vaccine DosesSemantic proximity Read

Low neutralization of SARS-CoV-2 Omicron BA.2.75.2, BQ.1.1, and XBB.1 by 4 doses of parental mRNA vaccine or a BA.5-bivalent boosterSemantic proximity Read

A survey and antibody test following the surge of SARS-CoV-2 Omicron infection in ChinaSemantic proximity Read

Recombinant XBB.1.5 boosters induce robust neutralization against KP.2- and KP.3-included JN.1 sublineagesSemantic proximity Read

Effect of Vaccine Booster, Vaccine Type, and Hybrid Immunity on Humoral and Cellular Immunity Against SARS-CoV-2 Ancestral Strain and Omicron Variant Sublineages BA.2 and BA.5 Among Older Adults with Comorbidities: An Observational StudySemantic proximity Read